Novartis, not to be outdone by respiratory rivals, inks ‘smart inhaler’ deal

Carly Helfand

drugmakers have been looking to "smart inhaler" technology to give them a leg up on marketing in a crowded field. And  wants a part of it. 

FiercePharma News

Share This Post

Related Articles

Leave a Reply

© 2018 Global Regulatory Science. All rights reserved. Site Admin · Entries RSS · Comments RSS